Biocon Chief says budget outlines comprehensive roadmap for sustained economic growth
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-02-02 07:30 GMT | Update On 2024-03-22 08:29 GMT
Advertisement
Bengaluru: Biotechnology industry veteran Kiran Mazumdar-Shaw on Thursday said in the interim budget, Union Finance Minister Nirmala Sitharaman has outlined a comprehensive roadmap for sustained economic growth that will enable India to achieve developed economy status by 2047. She termed it as an "all encompassing growth focused" budget, which augments inclusive economic development.
"In the interim budget, Finance Minister Nirmala Sitharaman has outlined a comprehensive roadmap for sustained economic growth that will enable India to achieve developed economy status by 2047. Her emphasis on research and innovation, bio manufacturing, robust infrastructure development, and technology-driven digital transformation augur well for India to deliver on aspirational yet people-centric, inclusive development," Mazumdar-Shaw posted on ''X".
The executive chairperson of Biocon Limited said, "No tax change, 'Viksit Bharat' mantra in last budget before polls - an all encompassing growth focused interim budget which augments inclusive economic development. Bio manufacturing and research financing to boost innovation and green technologies is positive."
In his reaction, Volvo Group in India President & MD Kamal Bali said, overall it is an "outstanding" interim budget.
"The interim budget by the FM continued upholding India's impetus on inclusive and sustainable growth, backed by responsible and efficient governance. It was a pleasant surprise to see aggressive fiscal deficit goals and stable macroeconomic performance, while furthering capex on physical infrastructure as well as DPI (Digital Public Infrastructure), he said in a statement.
The one-lakh crore support to technology and innovation is a very thoughtful and a compelling idea that will propel India on course to Viksit Bharat. Likewise, is the focus on farm sector and MSMEs, he added.
Porter CEO & Co-Founder Uttam Digga said driven by the goal of people-centric inclusive development, we appreciate the continued focus on developing MSMEs.
"With the aim to give them greater accessibility, affordability and availability, we are happy to see MSMEs receiving access to adequate finances, training and technology. MSMEs make up the backbone of the Indian economy, and this push will help them compete on a global scale," he said in a statement.
The commitment to meet the net zero target in 2070 is in line with our focus on green energy and EV ecosystems, he said, adding that "Building up manufacturing and charging infrastructure will increase confidence in EVs and encourage greater adoption among owner-cum-drivers."
The Federation of Karnataka Chambers of Commerce & Industry (FKCCI) welcomed the interim budget and said it is focused on making India a developed country.
Congratulating the government for not resorting to a populous budget and focusing on visible all-round development, it said, "We welcome the budget which is focused on the four priority sectors of Women, Youth, Farmers and the Poor which is aimed at quality growth rather than the quantity."
Read also: Powered by innovative drugs, pharma industry can be worth USD 200 billion by 2030: Biocon Chief
Original news source: https://www.ptinews.com/story/national/budget-outlines-comprehensive-roadmap-for-sustained-economic-growth-kiran-mazumdar-shaw/1258886
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.